ITGA2B and Miyoshi myopathy: Indeed, when we compared the distribution of the double positive CD41/61-HECA452 cells in samples from MM patients at diagnosis or relapse, we found a significant accumulation of this population at relapse (Figure 5D), suggesting that these cells could be selected by therapy.